Press Enter or click the Search button above to view results.

Recent Drug Updates

  • guselkumab (Tremfya) FDA approved for moderate-to-severe chronic plaque psoriasis in patients who are candidates for systemic therapy or phototherapy
  • glutamine (Endari) FDA approves for reducing severe complications associated with sickle cell disease
  • abatacept (Orencia) New indication approved for psoriatic arthritis